دارویی اسوه
داسوه | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 119,500 2.92
Close Price: 119,600
Income Statement
AGM
Interim
2026/04/18 Fiscal Year 2025/12/2112 Month | 2025/03/10 Fiscal Year 2024/12/2012 Month | 2024/03/13 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 9.217 Trillion | 7.676 Trillion | 7.099 Trillion | |
Total Revenues | 9.217 Trillion | 7.676 Trillion | 7.099 Trillion | |
Cost of Goods Sold | 5.553 Trillion | 6.434 Trillion | 4.848 Trillion | |
Gross Profit | 3.663 Trillion | 1.243 Trillion | 2.252 Trillion | |
General & Administrative Expenses | 698.207 Billion | 583.496 Billion | 478.528 Billion | |
Net Operating Income & Expenses | -115.274 Billion | -138.402 Billion | -23.531 Billion | |
Operating Profit (Loss) | 2.85 Trillion | 520.712 Billion | 1.75 Trillion | |
Profit Before Tax | 2.392 Trillion | 216.836 Billion | 1.638 Trillion | |
Tax | 617.864 Billion | 185.115 Billion | 253.602 Billion | |
Net Profit (Loss) After Tax | 1.774 Trillion | 31.721 Billion | 1.385 Trillion | |
Retained Earnings at Beginning of Period | 3.079 Trillion | 4.026 Trillion | 5.191 Trillion | |
Approved Dividends — Prior Year AGM | - | -975 Billion | -2.55 Trillion | |
Transfer from Other Equity Items | -10.313 Billion | -3.921 Billion | - | |
Allocable Profit | 4.843 Trillion | 3.079 Trillion | 4.026 Trillion | |
Approved Dividends — Current Year | 1.35 Trillion | - | 975 Billion | |
Retained Earnings at End of Period | 3.493 Trillion | 3.079 Trillion | 3.051 Trillion |